InnoCare Pharma Limited
OTC: INCPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jisong Cui
- Employees
- 1,089
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- $2.3B
- Website
- https://www.innocarepharma.com
Loading INCPF…
Loading profile data…Frequently asked questions about INCPF
What does InnoCare Pharma Limited (INCPF) do?
InnoCare Pharma Limited is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments, primarily targeting cancer and autoimmune disorders. A key product in their portfolio is Orelabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor. This therapy targets various relapsed or refractory blo...
Where does INCPF trade?
InnoCare Pharma Limited (INCPF) trades on the Other OTC.
What sector is INCPF in?
InnoCare Pharma Limited (INCPF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of InnoCare Pharma Limited?
Jisong Cui is the chief executive officer of InnoCare Pharma Limited (INCPF).
Where is InnoCare Pharma Limited headquartered?
InnoCare Pharma Limited is headquartered in China.
Does INCPF pay a dividend?
InnoCare Pharma Limited (INCPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INCPF go public?
InnoCare Pharma Limited (INCPF) completed its initial public offering in 2021.